VIKING GLOBAL INVESTORS LP·SCHEDULE 13D/A

Apr 2, 6:40 PM ET

BridgeBio Pharma, Inc. SCHEDULE 13D/A

SCHEDULE 13D/A · VIKING GLOBAL INVESTORS LP · Filed Apr 2, 2026

Documents

3 files